The role of LPCAT3 in pathogenesis of diabetic cardiomyopathy
LPCAT3在糖尿病心肌病发病机制中的作用
基本信息
- 批准号:10867671
- 负责人:
- 金额:$ 15.27万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-06-01 至 2025-05-31
- 项目状态:未结题
- 来源:
- 关键词:ATF6 geneAcuteAcyltransferaseAffectAgeAnimal ExperimentsAnimalsAntibodiesApoptosisAreaBiological AssayBloodBody CompositionBody WeightC57BL/6 MouseCD36 geneCardiacCardiac MyocytesCardiovascular DiseasesCaspaseCause of DeathCaymansCd68Cell LineCell ProliferationCell SurvivalCellsCeramidesChemicalsCholesterolCholesterol EstersCollaborationsComputer softwareContractsControl GroupsCustomCytomegalovirusDependovirusDevelopmentDiabetes MellitusDietDiet ResearchDiglyceridesDiseaseDoseDyslipidemiasEatingEnsureEnzymesEvaluationFastingFat-Restricted DietFatty acid glycerol estersFelis catusFutureGCG geneGRP78 geneGRP94Gene ExpressionGenotypeGenus HippocampusGlucoseGlucose tolerance testGlutamineGlycolysisHeart AbnormalitiesHeart failureHigh Fat DietHourHypertensionITGAM geneImageIncubatedIndividualInflammationInjectionsInsulinInsulin ResistanceInterleukin-4Interleukin-6Intraperitoneal InjectionsKnock-outKnockout MiceKnowledgeLaboratoriesLecithinLipid PeroxidationLipidsLipolysisLiverLiver X ReceptorLoxP-flanked alleleLysophosphatidylcholinesMass FragmentographyMeasuresMembraneMetabolicMetabolic DiseasesMetabolic PathwayMetabolismMicroscopeMitochondriaMolecularMonitorMusMyocardial dysfunctionMyosin Heavy ChainsNebraskaNon-Insulin-Dependent Diabetes MellitusNonesterified Fatty AcidsObese MiceObesityOilsOxidative PhosphorylationOxidative StressOxygen ConsumptionPalmitatesPancreasPathogenesisPatientsPharmacotherapyPhenotypePhospholipidsPhosphorylationPhysiologyPlasmaPlayPolyunsaturated Fatty AcidsPositioning AttributePrevention strategyProductionPromegaProteinsRNA SplicingReactive Oxygen SpeciesReceptor ActivationRespirationRisk FactorsRoleSOD2 geneSignal TransductionStainsStreptozocinStructureSupplementationSystemTNF geneTestingThe Jackson LaboratoryThiobarbituric Acid Reactive SubstancesTissuesTobacco useTransforming Growth Factor alphaUniversitiesUnsaturated Fatty AcidsVentricular Cardiac alpha-MyosinWestern BlottingWomanXBP1 genealpha Actinincontinuous cell linedb/db mousediabeticdiabetic cardiomyopathydiagnostic tooldietarydigitalendoplasmic reticulum stressexperimental groupexperimental studyextracellularfatty acid oxidationfeedingheart functionheart metabolismimprovedin vivoinsulin sensitivitylipid biosynthesislipidomelong chain fatty acidmalemennano-stringobesity preventionoverexpressionoxidationoxidative DNA damagepreventstandard measuresuperoxide dismutase 1transcription factortransduction efficiency
项目摘要
Cardiovascular diseases are the number one cause of death globally. Most CVDs are caused by risk
factors such as tobacco use, hypertension, obesity or diabetes. Diabetic cardiomyopathy (DC) is
characterized by abnormal cardiac structure and function in the absence of other cardiac risk factors and
is often undiagnosed in patients with diabetes mellitus. Untreated, this condition increases the chance of
heart failure at least 2.4-fold in men and 5.1-fold in women compared to individuals without diabetes.
Despite the increase in the number of cases in the past several decades, the underlying molecular
mechanisms of DC pathogenesis remain poorly understood, thereby preventing the development of
effective diagnostic tools and pharmacotherapies as well as preventive strategies. One of the emerging
hypothesis is that altered membrane polyunsaturated fatty acid composition can activate ER stress
signaling, oxidative stress and inflammation in cells. It has been speculated that increased membrane
phospholipid saturation may be an underlying cause of many metabolic disorders.
Lysophosphatidylcholine acyltransferase 3 (LPCAT3) is a major cardiac enzyme that catalyzes the
formation of phosphatidylcholine (PC) from lysophosphatidylcholine. LPCAT3 preferentially synthesizes
PC containing unsaturated fatty acids at the sn-2 position. A recent study has shown that LPCAT3
overexpression in livers of obese diabetic db/db mice effectively reduced ER stress by modulating PC
saturation. However, the role of LPCAT3 in cardiac metabolism is very poorly understood. Therefore, the
proposed project aims at establishing the role of LPCAT3 in cardiac function and investigating the effect
that LPCAT3 deficiency may play in development of DC. Additionally, the project will investigate the
potential of PC supplemented diet to improve cardiac function in obese mice. Finally, the proposed study
will investigate the potential of LPCAT3 overexpression through its transcription factor - liver X receptor
(LXR) activation on improving cardiomyocyte structure and function in acute lipotoxicity.
心血管疾病是全球第一大死亡原因。大多数CVD是由风险引起的
吸烟、高血压、肥胖或糖尿病等因素。糖尿病心肌病(DC)是
其特征是在没有其他心脏危险因素的情况下心脏结构和功能异常,并且
糖尿病患者常常无法确诊。如果不进行治疗,这种情况会增加以下风险:
与未患糖尿病的人相比,男性心力衰竭的发生率至少高 2.4 倍,女性心力衰竭的发生率至少高 5.1 倍。
尽管过去几十年来病例数量有所增加,但潜在的分子机制
DC 发病机制仍知之甚少,从而阻碍了 DC 的发展
有效的诊断工具和药物治疗以及预防策略。新兴的之一
假设改变膜多不饱和脂肪酸成分可以激活内质网应激
细胞内的信号传导、氧化应激和炎症。据推测,增加膜
磷脂饱和可能是许多代谢紊乱的根本原因。
溶血磷脂酰胆碱酰基转移酶 3 (LPCAT3) 是一种主要的心肌酶,可催化
从溶血磷脂酰胆碱形成磷脂酰胆碱(PC)。 LPCAT3优先合成
PC的sn-2位含有不饱和脂肪酸。最近的一项研究表明 LPCAT3
肥胖糖尿病 db/db 小鼠肝脏中的过度表达通过调节 PC 有效降低 ER 应激
饱和。然而,人们对 LPCAT3 在心脏代谢中的作用知之甚少。因此,
拟议项目旨在确定 LPCAT3 在心脏功能中的作用并研究其影响
LPCAT3 缺陷可能在 DC 的发展中发挥作用。此外,该项目还将调查
PC补充饮食改善肥胖小鼠心脏功能的潜力。最后,提出的研究
将研究 LPCAT3 通过其转录因子 - 肝脏 X 受体过度表达的潜力
(LXR) 激活可改善急性脂毒性中心肌细胞的结构和功能。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Tomasz Krzysztof Bednarski其他文献
Tomasz Krzysztof Bednarski的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似国自然基金
巨噬细胞Nogo-B通过FABP4/IL-18/IL-18R调控急性肝衰竭的分子机制研究
- 批准号:82304503
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
α7nAChR激动剂通过PGC-1α和HO-1调控肾小管上皮细胞线粒体的质和量进而改善脓毒症急性肾损伤的机制研究
- 批准号:82372172
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
基于解郁散热“把好气分关”探讨代谢-炎症“开关”A2BR在急性胰腺炎既病防变中的作用与机制
- 批准号:82374256
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
RacGAP1介导细胞核-线粒体对话在急性肾损伤中促进肾小管上皮细胞能量平衡的作用机制研究
- 批准号:82300771
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
开窍寒温配伍调控应激颗粒铁离子富集水平抗急性缺血性卒中铁死亡损伤的机制研究
- 批准号:82374209
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
相似海外基金
Microbial adaptation of Pseudomonas lipid A structure in CF airway disease progress
假单胞菌脂质 A 结构在 CF 气道疾病进展中的微生物适应
- 批准号:
10722599 - 财政年份:2023
- 资助金额:
$ 15.27万 - 项目类别:
Oxidative Lipidomics in Pediatric Traumatic Brain Injury
氧化脂质组学在小儿创伤性脑损伤中的应用
- 批准号:
10844023 - 财政年份:2023
- 资助金额:
$ 15.27万 - 项目类别:
Novel Mechanisms Underlying the Development of Atherosclerosis
动脉粥样硬化发展的新机制
- 批准号:
10589484 - 财政年份:2023
- 资助金额:
$ 15.27万 - 项目类别:
Cholesterol toxicity in alcohol-associated hepatitis
酒精相关性肝炎中的胆固醇毒性
- 批准号:
10637154 - 财政年份:2023
- 资助金额:
$ 15.27万 - 项目类别: